Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib

Dove Press, Breast Cancer: Targets and Therapy, (Volume 13), p. 361-381, 2021

Journal article published in 2021 by Lara Ulrich, Alicia Fc Okines

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by